Amniotic fluid-soluble vascular endothelial growth factor receptor-1 in preeclampsia

Obstetrics and Gynecology

Volumn 95, Issue 3, 2000, Pages 353-357

  Vuorela, Piia ^a,b,c   Helske, Satu ^a,b,c   Hornig, Carsten ^a,b,c   Alitalo, Kari ^a,b,c   Weich, Herbert ^a,b,c   Halmesmäki, Erja ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Division of Molecular Biotechnology   (Germany)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; VASCULOTROPIN;

ADULT; AMNION FLUID; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOXIA; PLACENTA; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AMNIOTIC FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 0033970164     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00565-7     Document Type: Article

References (22)

1. Robertson W.B., Khong T.Y., Brosens I., De Wolf F., Sheppard B.L., Bonnar J. The placental bed biopsy Review from three European centers . Am J Obstet Gynecol. 155:1986;401-412.
2. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Pre-eclampsia An endothelial cell disorder . Am J Obstet Gynecol. 161:1989;1200-1204.
3. Caro J., Erslev A.J., Silver R., Miller O., Birgegard G. Erythropoietin production in response to anemia or hypoxia in the newborn rat. Blood. 60:1982;984-988.
4. Goldberg M.A., Schneider T.J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem. 269:1994;4355-4359.
5. Ferrara N. Vascular endothelial growth factor Molecular and biological aspects . Claesson-Welsh L. Vascular growth factors and angiogenesis. 1999;1-30 Springer-Verlag, Berlin.
6. Vuorela P., Hatva E., Lymboussaki A., Kaipainen A., Joukov V., Persico M.G., et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod. 56:1997;489-494.
7. Kendall R.L., Thomas K.A. Inhibition of vascular endothelial growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A. 90:1993;10705-10709.
8. Banks R.E., Forbes M.A., Searles J., Pappin D., Canas B., Rahman D., et al. Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol Hum Reprod. 4:1998;377-386.
9. Cooper J.C., Sharkey A.M., Charnock-Jones D.S., Palmer C.R., Smith S.K. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol. 103:1996;1191-1196.
10. Kupferminc M.J., Daniel Y., Englender T., Baram A., Many A., Jaffa A.J., et al. Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol. 38:1997;302-306.
11. Lyall F., Greer I.A., Boswell F., Fleming R. Suppression of vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol. 104:1997;223-228.
12. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 331:1994;1480-1487.
13. Hornig C., Behn T., Bartsch W., Yayon A., Weich H.A. Detection and quantification of complexed and free soluble human vascular endothelial growth factor receptor-1 (sVEGFR-1) by ELISA. J Immunol Methods. 226:1999;169-177.
14. Teramo K.A., Widness J.A., Clemons G.K., Voutilainen P., McKinlay S., Schwartz R. Amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancy. Obstet Gynecol. 69:1987;710-716.
15. Shibuya M., Ito N., Claesson-Welsh L. Structure and function of vascular endothelial growth factor receptor-1 and -2. Claesson-Welsh L. Vascular growth factors and angiogenesis. 1999;59-84 Springer-Verlag, Heidelberg, Germany.
16. Olofsson B., Pajusola K., Kaipainen A., von Euler G., Joukov V., Saksela O., et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A. 93:1996;2576-2581.
17. Dumont D.J., Jussila L., Taipale J., Lymboussaki A., Mustonen T., Pajusola K., et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 282:1998;946-949.
18. Natarajan R., Bai W., Lanting L., Gonzales N., Nadler J. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol. 273:1997;H2224-H2231.
19. Brooks S.E., Gu X., Kaufmann P.M., Marcus D.M., Caldwell R.B. Modulation of VEGF production by pH and glucose in retinal Müller cells. Curr Eye Res. 17:1998;875-882.
20. Conrad K.P., Benyo D.F., Westerhausen-Larsen A., Miles T.M. Expression of erythropoietin by the human placenta. FASEB J. 10:1996;760-768.
21. Alvarez Arroyo M.V., Castilla M.A., Gonzalez Pacheco F.R., Tan D., Riesco A., Casado S., et al. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation. J Am Soc Nephrol. 9:1998;1998-2004.
22. Gerber H.P., Condorelli F., Park J., Ferrara N. Differential transscriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem. 272:1997;23659-23667.